Charles R. Romp - Jul 3, 2023 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
EVP, Commercial U.S.
Signature
By: /s/ Jennifer Prosba For: Charles R. Romp
Stock symbol
SGEN
Transactions as of
Jul 3, 2023
Transactions value $
-$136,262
Form type
4
Date filed
7/5/2023, 08:18 PM
Previous filing
May 18, 2023
Next filing
Aug 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Sale -$136K -708 -1.18% $192.46 59.1K Jul 3, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a written plan adopted on July 25, 2019 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.